AFFINITYSCAN Trademark

Trademark Overview


On Wednesday, July 13, 2022, a trademark application was filed for AFFINITYSCAN with the United States Patent and Trademark Office. The USPTO has given the AFFINITYSCAN trademark a serial number of 97501427. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, February 11, 2025. This trademark is owned by EUROFINS DISCOVERX CORPORATION. The AFFINITYSCAN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Scientific and technological services, namely, drug discovery and development services, research discovery and development services, pharmaceuticals research services in the field of biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Scientific research; Scientific research and development; Scientific research consulting; Scientific research consulting in the field of drug discovery and development, research discovery and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Scientific study and research in the field(s) of research discovery and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical...
affinityscan

General Information


Serial Number97501427
Word MarkAFFINITYSCAN
Filing DateWednesday, July 13, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkAFFINITY SCAN
Goods and ServicesPharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Scientific and technological services, namely, drug discovery and development services, research discovery and development services, pharmaceuticals research services in the field of biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Scientific research; Scientific research and development; Scientific research consulting; Scientific research consulting in the field of drug discovery and development, research discovery and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Scientific study and research in the field(s) of research discovery and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Providing scientific information in the field of drug discovery services, scientific and technological services, pharma research services for research and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and bipharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 2, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEUROFINS DISCOVERX CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Trademark Events


Event DateEvent Description
Saturday, July 16, 2022NEW APPLICATION ENTERED
Tuesday, August 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 27, 2023ASSIGNED TO EXAMINER
Thursday, May 18, 2023NON-FINAL ACTION WRITTEN
Thursday, May 18, 2023NON-FINAL ACTION E-MAILED
Thursday, May 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 21, 2023SUSPENSION LETTER WRITTEN
Monday, August 21, 2023LETTER OF SUSPENSION E-MAILED
Monday, August 21, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 21, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, February 11, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 13, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION